抗菌肽LL-37及其截短形式GI-20和GF-17具有杀精作用及抗淋病奈瑟菌微生物活性
本研究评价截短LL-37肽GI-20和GF-17的杀精及抗淋病奈瑟菌活性。体外和体内实验显示,GI-20和GF-17对小鼠和人精子有杀精作用,对淋病奈瑟菌有杀菌作用,效力与LL-37相同,且对雌鼠生殖道组织无损伤。
要点
- GI-20和GF-17对小鼠和人精子均有杀精作用,效力与LL-37相同。
- GI-20和GF-17对淋病奈瑟菌的杀菌作用与LL-37相同。
- GI-20和GF-17处理雌鼠生殖道组织未见病变、糜烂或溃疡。
核心结论
- GI-20和GF-17与LL-37一样,具有杀精作用及抗淋病奈瑟菌微生物活性,且对雌性生殖道组织无不良影响。
研究设计与样本
- 体外评估GI-20和GF-17对小鼠和人精子的杀精活性,并在小鼠体内评估;体外测定LL-37、GI-20和GF-17对淋病奈瑟菌的抗菌效果;所有实验重复三次或以上。
主要发现
- GI-20和GF-17处理精子导致剂量依赖性精子质膜通透性增加,人精子在18 μM、小鼠精子在3.6 μM时达最大效应(P < 0.0001,与未处理精子相比)。
- 3.6 μM GI-20或GF-17处理的小鼠精子在体外和体内均不能使卵母细胞受精。
- 预先暴露于3.6 μM GI-20或GF-17的雌鼠生殖道组织保持完整,无病变、糜烂或溃疡。
- 在1.8-7.2 μM浓度下,LL-37、GI-20和GF-17对淋病奈瑟菌发挥杀菌作用。
局限性
- 由于伦理问题,无法直接证明GI-20和GF-17对人群体外和体内受精的抑制作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do the truncated LL-37 peptides, GI-20 and GF-17, have spermicidal activity and microbicidal effects on the sexually transmitted infection (STI) pathogen Neisseria gonorrhoeae with equivalent potency to LL-37? SUMMARY ANSWER: GI-20 and GF-17 exhibited spermicidal effects on both mouse and human sperm as well as microbicidal action on N. gonorrhoeae with the same efficacy as LL-37. WHAT IS KNOWN ALREADY: The antimicrobial peptide LL-37 exerts microbicidal activity against various STI pathogens as well as spermicidal effects on both mouse and human sperm. STUDY DESIGN, SIZE, DURATION: Spermicidal activities of GI-20 and GF-17 were evaluated in vitro in mouse and human sperm and in vivo in mice. Finally, in vitro antimicrobial effects of LL-37, GI-20 and GF-17 on an STI pathogen, N. gonorrhoeae were determined. All experiments were repeated three times or more. In particular, sperm samples from different males were used on each experimental day. PARTICIPANTS/MATERIALS, SETTING, METHODS: The plasma membrane integrity of peptide-treated sperm was assessed by cellular exclusion of Sytox Green, a membrane impermeable fluorescent DNA dye. Successful mouse in vitro fertilization was revealed by the presence of two pronuclei in oocytes following co-incubation with capacitated untreated/peptide-pretreated sperm. Sperm plus each peptide were transcervically injected into female mice and the success of in vivo fertilization was scored by the formation of 2-4 cell embryos 42 h afterward. Reproductive tract tissues of peptide pre-exposed females were then assessed histologically for any damage. Minimal inhibitory/bactericidal concentrations of LL-37, GI-20 and GF-17 on N. gonorrhoeae were determined by a standard method. MAIN RESULTS AND THE ROLE OF CHANCE: Like LL-37, treatment of sperm with GI-20 and GF-17 resulted in dose-dependent increases in sperm plasma membrane permeabilization, reaching the maximum at 18 and 3.6 μM for human and mouse sperm, respectively (P < 0.0001, as compared with untreated sperm). Mouse sperm treated with 3.6 μM GI-20 or GF-17 did not fertilize oocytes either in vitro or in vivo. Moreover, reproductive tract tissues of female mice pre-exposed to 3.6 μM GI-20 or GF-17 remained intact with no lesions, erosions or ulcerations. At 1.8-7.2 μM, LL-37, GI-20 and GF-17 exerted bactericidal effects on N. gonorrhoeae. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Direct demonstration of the inhibitory effects of GI-20 and GF-17 on human in vitro and in vivo fertilization cannot be performed due to ethical issues. WIDER IMPLICATIONS OF THE FINDINGS: Like LL-37, GI-20 and GF-17 acted as spermicides and microbicides against N. gonorrhoeae, without adverse effects on female reproductive tissues. With lower synthesis costs, GI-20 and GF-17 are attractive peptides for further development into vaginal spermicides/microbicides. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by Canadian Institutes of Health Research (MOP119438 and CCI82413 to N.T.) and NIH (R01 AI105147 to G.W.). There are no competing interests to declare.
引用
- Kiattiburut W, Zhi R, Lee SG, et al. Antimicrobial peptide LL-37 and its truncated forms, GI-20 and GF-17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae. Hum Reprod. 2018. PMID: 30357408. doi:10.1093/humrep/dey315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。